Systemic immunosuppressant for betterment of ocular manifestations of secondary Sjogren’s: A case report
| Autor: | Mohammed Haneef, Lessitha N K, Vasantha N, Shalet Paul, Haleema A |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
musculoskeletal diseases
Secondary Sjögren Syndrome medicine.medical_specialty genetic structures business.industry medicine.disease Dermatology eye diseases Ophthalmic pathology Neuro-ophthalmology stomatognathic diseases Immune system stomatognathic system Rheumatoid arthritis Sjogrens syndrome medicine Pediatric ophthalmology Sjogren s business |
| Zdroj: | IP International Journal of Ocular Oncology and Oculoplasty. 6:226-228 |
| ISSN: | 2581-5016 2581-5024 |
| DOI: | 10.18231/j.ijooo.2020.051 |
| Popis: | Secondary sjogrens syndrome is an autoimmune disorder leading to destruction of exocrine glands with resultant classical clinical triad of dry eye, dry mouth and parotid gland enlargement in association with other systemic autoimmune diseasecommonly rheumatoid arthritis. This report highlights the unintended effect of systemic immunosuppresants given for the treatment of rheumatoid arthritis, in improving the coexistant corneal thinning and other ocular manifestation in a case ofsecondary sjogrens syndrome, which has been rarely reported. Key Messages: Modification of the immune response with systemic immunosuppressive agents improves severe keratoconjunctivitis sicca in recalcitrant secondary Sjogren syndrome. Keywords: Secondary Sjogren’s, Systemic immunosuppressant, Dry eye. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|